Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
SURPASS-2: The Direct Head-to-Head Trial The most important direct comparison is the SURPASS-2 trial, published in the New England Journal of Medicine (Fras et al., 2021)
Estimated reading time: 7 minutes Retatrutide has quickly become one of the most talked-about medications in obesity medicine, and it isnt even approved by the U.S
WellMedr Pricing Listed in Brand Materials At the time this article was prepared, WellMedr's published materials listed compounded semaglutide starting at $88 per month, compounded tirzepatide starting at $158 per month, Ozempic starting at $1,399 per month, and Zepbound starting at $1,599 per month
Jul 2019;2(3):e00047
Retatrutide effects begin gradually
Obesity is a breast cancer risk factor, which means maintaining a healthy weight can help reduce the possibility of developing cancer
US$ 20.37
US$ 23.43
US$ 25.15
US$ 24.13
US$ 29.33
US$ 20.22
US$ 21.81
US$ 21.55
US$ 23.33
